The estimated Net Worth of Patrick Weiss is at least $5.44 million dollars as of 21 December 2021. Mr Weiss owns over 3,918 units of Twist Bioscience Corp stock worth over $1,932,765 and over the last 6 years he sold TWST stock worth over $2,724,824. In addition, he makes $786,406 as Chief Operating Officer at Twist Bioscience Corp.
Mr has made over 28 trades of the Twist Bioscience Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,918 units of TWST stock worth $324,606 on 21 December 2021.
The largest trade he's ever made was exercising 40,000 units of Twist Bioscience Corp stock on 14 December 2020 worth over $984,800. On average, Mr trades about 5,001 units every 16 days since 2018. As of 21 December 2021 he still owns at least 43,570 units of Twist Bioscience Corp stock.
You can see the complete history of Mr Weiss stock trades at the bottom of the page.
Patrick Weiss is the Chief Operating Officer at Twist Bioscience Corp.
As the Chief Operating Officer of Twist Bioscience Corp, the total compensation of Mr Weiss at Twist Bioscience Corp is $786,406. There are 4 executives at Twist Bioscience Corp getting paid more, with Emily Leproust having the highest compensation of $8,126,160.
Mr Weiss is 50, he's been the Chief Operating Officer of Twist Bioscience Corp since . There are 15 older and 7 younger executives at Twist Bioscience Corp. The oldest executive at Twist Bioscience Corp is Dr. William Charles Banyai Ph.D., 66, who is the Sr. VP of Advanced Devel., GM of Data Storage & Director.
Patrick's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell et Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: